Pro Share Advisors LLC Repligen Corp Transaction History

Pro Share Advisors LLC

  • $48.7 Billion
  • Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Repligen Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 2,316 shares of RGEN stock, worth $343,694. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,316
Previous 2,220 4.32%
Holding current value
$343,694
Previous $282,000 2.13%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
BUY
$108.89 - $145.23 $10,453 - $13,942
96 Added 4.32%
2,316 $288,000
Q1 2025

May 08, 2025
SELL
$127.24 - $174.24 $27,738 - $37,984
-218 Reduced 8.94%
2,220 $282,000
Q4 2024

Feb 13, 2025
BUY
$123.41 - $160.92 $20,609 - $26,873
167 Added 7.35%
2,438 $350,000
Q3 2024

Nov 13, 2024
SELL
$119.79 - $167.35 $21,562 - $30,123
-180 Reduced 7.34%
2,271 $337,000
Q2 2024

Aug 13, 2024
SELL
$120.0 - $182.95 $9,840 - $15,001
-82 Reduced 3.24%
2,451 $308,000
Q1 2024

May 08, 2024
SELL
$170.78 - $208.42 $33,814 - $41,267
-198 Reduced 7.25%
2,533 $465,000
Q4 2023

Feb 14, 2024
SELL
$114.17 - $185.35 $7,991 - $12,974
-70 Reduced 2.5%
2,731 $491,000
Q3 2023

Nov 13, 2023
SELL
$138.78 - $176.51 $31,086 - $39,538
-224 Reduced 7.4%
2,801 $445,000
Q2 2023

Aug 10, 2023
SELL
$138.42 - $180.31 $6,505 - $8,474
-47 Reduced 1.53%
3,025 $427,000
Q1 2023

May 11, 2023
SELL
$154.26 - $198.1 $137,754 - $176,903
-893 Reduced 22.52%
3,072 $517,000
Q4 2022

Feb 02, 2023
BUY
$162.42 - $220.56 $52,136 - $70,799
321 Added 8.81%
3,965 $671,000
Q3 2022

Nov 04, 2022
SELL
$160.42 - $256.21 $5,454 - $8,711
-34 Reduced 0.92%
3,644 $682,000
Q2 2022

Aug 01, 2022
SELL
$140.68 - $188.02 $202,579 - $270,748
-1,440 Reduced 28.14%
3,678 $597,000
Q1 2022

May 10, 2022
SELL
$161.19 - $257.96 $131,047 - $209,721
-813 Reduced 13.71%
5,118 $962,000
Q4 2021

Feb 08, 2022
BUY
$247.59 - $304.47 $294,632 - $362,319
1,190 Added 25.1%
5,931 $1.57 Million
Q3 2021

Nov 12, 2021
SELL
$194.77 - $324.21 $187,173 - $311,565
-961 Reduced 16.85%
4,741 $1.37 Million
Q2 2021

Aug 13, 2021
BUY
$165.87 - $220.95 $137,008 - $182,504
826 Added 16.94%
5,702 $1.14 Million
Q1 2021

May 14, 2021
BUY
$180.37 - $226.26 $5,411 - $6,787
30 Added 0.62%
4,876 $948,000
Q4 2020

Feb 09, 2021
BUY
$148.08 - $206.57 $104,692 - $146,044
707 Added 17.08%
4,846 $929,000
Q3 2020

Nov 13, 2020
BUY
$122.51 - $158.27 $32,342 - $41,783
264 Added 6.81%
4,139 $611,000
Q2 2020

Aug 03, 2020
SELL
$94.33 - $140.48 $164,039 - $244,294
-1,739 Reduced 30.98%
3,875 $479,000
Q1 2020

May 15, 2020
SELL
$84.96 - $109.14 $557,507 - $716,176
-6,562 Reduced 53.89%
5,614 $542,000
Q4 2019

Feb 12, 2020
BUY
$73.84 - $93.08 $125,749 - $158,515
1,703 Added 16.26%
12,176 $1.13 Million
Q3 2019

Nov 12, 2019
BUY
$76.65 - $95.51 $393,137 - $489,870
5,129 Added 95.98%
10,473 $803,000
Q2 2019

Aug 13, 2019
SELL
$54.2 - $85.95 $1,571 - $2,492
-29 Reduced 0.54%
5,344 $459,000
Q1 2019

May 15, 2019
BUY
$49.45 - $62.8 $8,060 - $10,236
163 Added 3.13%
5,373 $317,000
Q4 2018

Feb 14, 2019
SELL
$48.26 - $68.88 $889,045 - $1.27 Million
-18,422 Reduced 77.95%
5,210 $275,000
Q3 2018

Nov 14, 2018
SELL
$46.8 - $58.97 $51,058 - $64,336
-1,091 Reduced 4.41%
23,632 $1.31 Million
Q2 2018

Aug 13, 2018
SELL
$35.26 - $47.04 $49,152 - $65,573
-1,394 Reduced 5.34%
24,723 $1.16 Million
Q1 2018

May 14, 2018
SELL
$30.92 - $37.27 $125,813 - $151,651
-4,069 Reduced 13.48%
26,117 $945,000
Q4 2017

Feb 14, 2018
BUY
$32.53 - $38.92 $189,845 - $227,137
5,836 Added 23.97%
30,186 $1.1 Million
Q3 2017

Nov 13, 2017
BUY
$36.98 - $46.06 $121,220 - $150,984
3,278 Added 15.56%
24,350 $933,000
Q2 2017

Aug 11, 2017
BUY
N/A
21,072
21,072 $873,000

Others Institutions Holding RGEN

# of Institutions
506
Shares Held
58.9M
Call Options Held
89.3K
Put Options Held
679K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.23B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email